225 related articles for article (PubMed ID: 28858475)
1. Dysprosium-Modified Tobacco Mosaic Virus Nanoparticles for Ultra-High-Field Magnetic Resonance and Near-Infrared Fluorescence Imaging of Prostate Cancer.
Hu H; Zhang Y; Shukla S; Gu Y; Yu X; Steinmetz NF
ACS Nano; 2017 Sep; 11(9):9249-9258. PubMed ID: 28858475
[TBL] [Abstract][Full Text] [Related]
2. Polydopamine-decorated tobacco mosaic virus for photoacoustic/magnetic resonance bimodal imaging and photothermal cancer therapy.
Hu H; Yang Q; Baroni S; Yang H; Aime S; Steinmetz NF
Nanoscale; 2019 May; 11(19):9760-9768. PubMed ID: 31066418
[TBL] [Abstract][Full Text] [Related]
3. A novel plectin/integrin-targeted bispecific molecular probe for magnetic resonance/near-infrared imaging of pancreatic cancer.
Wang Q; Yan H; Jin Y; Wang Z; Huang W; Qiu J; Kang F; Wang K; Zhao X; Tian J
Biomaterials; 2018 Nov; 183():173-184. PubMed ID: 30172243
[TBL] [Abstract][Full Text] [Related]
4. Nitroxyl Modified Tobacco Mosaic Virus as a Metal-Free High-Relaxivity MRI and EPR Active Superoxide Sensor.
Dharmarwardana M; Martins AF; Chen Z; Palacios PM; Nowak CM; Welch RP; Li S; Luzuriaga MA; Bleris L; Pierce BS; Sherry AD; Gassensmith JJ
Mol Pharm; 2018 Aug; 15(8):2973-2983. PubMed ID: 29771534
[TBL] [Abstract][Full Text] [Related]
5. Novel α(2)β(1) integrin-targeted peptide probes for prostate cancer imaging.
Huang CW; Li Z; Cai H; Shahinian T; Conti PS
Mol Imaging; 2011 Aug; 10(4):284-94. PubMed ID: 21486537
[TBL] [Abstract][Full Text] [Related]
6. Integrin α2β1 targeted GdVO4:Eu ultrathin nanosheet for multimodal PET/MR imaging.
Hu H; Li D; Liu S; Wang M; Moats R; Conti PS; Li Z
Biomaterials; 2014 Oct; 35(30):8649-58. PubMed ID: 25043573
[TBL] [Abstract][Full Text] [Related]
7. Physalis Mottle Virus-like Nanoparticles for Targeted Cancer Imaging.
Hu H; Masarapu H; Gu Y; Zhang Y; Yu X; Steinmetz NF
ACS Appl Mater Interfaces; 2019 May; 11(20):18213-18223. PubMed ID: 31074602
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous Iron Oxide/Dysprosium Oxide Nanoparticles Target Liver for Precise Magnetic Resonance Imaging of Liver Fibrosis.
Balachandran YL; Wang W; Yang H; Tong H; Wang L; Liu F; Chen H; Zhong K; Liu Y; Jiang X
ACS Nano; 2022 Apr; 16(4):5647-5659. PubMed ID: 35312295
[TBL] [Abstract][Full Text] [Related]
9. Cancer Theranostic Applications of Albumin-Coated Tobacco Mosaic Virus Nanoparticles.
Pitek AS; Hu H; Shukla S; Steinmetz NF
ACS Appl Mater Interfaces; 2018 Nov; 10(46):39468-39477. PubMed ID: 30403330
[TBL] [Abstract][Full Text] [Related]
10. Cross-linked magnetic nanoparticles with a biocompatible amide bond for cancer-targeted dual optical/magnetic resonance imaging.
Yang HM; Park CW; Park S; Kim JD
Colloids Surf B Biointerfaces; 2018 Jan; 161():183-191. PubMed ID: 29080502
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid formulation of near infrared fluorophores optimizes surgical imaging in a prostate tumor xenograft.
Souchek JJ; Wojtynek NE; Payne WM; Holmes MB; Dutta S; Qi B; Datta K; LaGrange CA; Mohs AM
Acta Biomater; 2018 Jul; 75():323-333. PubMed ID: 29890268
[TBL] [Abstract][Full Text] [Related]
12. Structure and dysprosium dopant engineering of gadolinium oxide nanoparticles for enhanced dual-modal magnetic resonance and fluorescence imaging.
Yin J; Li C; Chen D; Yang J; Liu H; Hu W; Shao Y
Phys Chem Chem Phys; 2017 Feb; 19(7):5366-5376. PubMed ID: 28155924
[TBL] [Abstract][Full Text] [Related]
13. In vivo near-infrared fluorescence imaging of integrin α2β1 in prostate cancer with cell-penetrating-peptide-conjugated DGEA probe.
Huang CW; Li Z; Conti PS
J Nucl Med; 2011 Dec; 52(12):1979-86. PubMed ID: 22065876
[TBL] [Abstract][Full Text] [Related]
14. Theranostic imaging of liver cancer using targeted optical/MRI dual-modal probes.
Chen Q; Shang W; Zeng C; Wang K; Liang X; Chi C; Liang X; Yang J; Fang C; Tian J
Oncotarget; 2017 May; 8(20):32741-32751. PubMed ID: 28416757
[TBL] [Abstract][Full Text] [Related]
15. Cy5.5 conjugated MnO nanoparticles for magnetic resonance/near-infrared fluorescence dual-modal imaging of brain gliomas.
Chen N; Shao C; Li S; Wang Z; Qu Y; Gu W; Yu C; Ye L
J Colloid Interface Sci; 2015 Nov; 457():27-34. PubMed ID: 26151564
[TBL] [Abstract][Full Text] [Related]
16. Paramagnetic dysprosium oxide nanoparticles and dysprosium hydroxide nanorods as T₂ MRI contrast agents.
Kattel K; Park JY; Xu W; Kim HG; Lee EJ; Bony BA; Heo WC; Jin S; Baeck JS; Chang Y; Kim TJ; Bae JE; Chae KS; Lee GH
Biomaterials; 2012 Apr; 33(11):3254-61. PubMed ID: 22277624
[TBL] [Abstract][Full Text] [Related]
17. In vivo MR and Fluorescence Dual-modality Imaging of Atherosclerosis Characteristics in Mice Using Profilin-1 Targeted Magnetic Nanoparticles.
Wang Y; Chen J; Yang B; Qiao H; Gao L; Su T; Ma S; Zhang X; Li X; Liu G; Cao J; Chen X; Chen Y; Cao F
Theranostics; 2016; 6(2):272-86. PubMed ID: 26877785
[TBL] [Abstract][Full Text] [Related]
18. Encapsulated gadolinium and dysprosium ions within ultra-short carbon nanotubes for MR microscopy at 11.75 and 21.1 T.
Rosenberg JT; Cisneros BT; Matson M; Sokoll M; Sachi-Kocher A; Bejarano FC; Wilson LJ; Grant SC
Contrast Media Mol Imaging; 2014; 9(1):92-9. PubMed ID: 24470298
[TBL] [Abstract][Full Text] [Related]
19. Dual-modal magnetic resonance and fluorescence imaging of atherosclerotic plaques in vivo using VCAM-1 targeted tobacco mosaic virus.
Bruckman MA; Jiang K; Simpson EJ; Randolph LN; Luyt LG; Yu X; Steinmetz NF
Nano Lett; 2014 Mar; 14(3):1551-8. PubMed ID: 24499194
[TBL] [Abstract][Full Text] [Related]
20. Redox-responsive dextran based theranostic nanoparticles for near-infrared/magnetic resonance imaging and magnetically targeted photodynamic therapy.
Ding Z; Liu P; Hu D; Sheng Z; Yi H; Gao G; Wu Y; Zhang P; Ling S; Cai L
Biomater Sci; 2017 Mar; 5(4):762-771. PubMed ID: 28256661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
